Jane Street
PHIO icon

Jane Street’s Phio Pharmaceuticals PHIO Stock Holding History

Jane Street’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
117,755
-1,434
-1% -$1.63K ﹤0.01% 10491
2026
Q1 		$145K Buy
+119,189
New +$136K ﹤0.01% 10416
2015
Q3 		– Hold
0
– -$5K – 4019
2015
Q2 		– Hold
0
– – – 3572
2014
Q4 		– Hold
0
– -$56K – 2900
2014
Q3 		– Hold
0
– – – 2411
2014
Q2 		– Hold
0
– – – 2226
2014
Q1 		– Hold
0
– – – 2420

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street's PHIO Position: Q2 2026 in Review

Jane Street reduced its Phio Pharmaceuticals (PHIO) stake by 1.2% in Q2 2026, selling an estimated $1.63K and leaving 117,755 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #10491.

Jane Street first reported a position in PHIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $145K in Q1 2026. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

  • Jane Street held 117,755 shares of Phio Pharmaceuticals worth $121K as of Q2 2026.
  • Jane Street sold 1,434 Phio Pharmaceuticals shares in Q2 2026, an estimated $1.63K.
  • Phio Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10491 holding.
  • Jane Street first reported a position in Phio Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Jane Street's Phio Pharmaceuticals position peaked at $145K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.